Biotech Co. Overstated Research Credit, Tax Court Says
By Anna Scott Farrell · May 17, 2023, 6:38 PM EDT
A biotechnology company overstated its research credit for 2014 by improperly excluding clinical testing expenses, the U.S. Tax Court ruled Wednesday, upholding a notice of deficiency from the Internal Revenue Service....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login